DDX19B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.061800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.236840E-01
Normal-vs-Stage2
6.979200E-01
Normal-vs-Stage3
3.758000E-01
Normal-vs-Stage4
4.244200E-01
Stage1-vs-Stage2
1.676560E-01
Stage1-vs-Stage3
9.620600E-01
Stage1-vs-Stage4
4.819600E-02
Stage2-vs-Stage3
2.384400E-01
Stage2-vs-Stage4
7.115500E-02
Stage3-vs-Stage4
1.654580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.063400E-01
Normal-vs-AfricanAmerican
6.753200E-01
Normal-vs-Asian
2.214200E-01
Caucasian-vs-AfricanAmerican
9.303200E-01
Caucasian-vs-Asian
1.400620E-01
AfricanAmerican-vs-Asian
2.451400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.012400E-01
Normal-vs-Female
6.833000E-01
Male-vs-Female
8.149200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.612400E-01
Normal-vs-Age(41-60Yrs)
6.849000E-01
Normal-vs-Age(61-80Yrs)
6.548800E-01
Normal-vs-Age(81-100Yrs)
9.054400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.822800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.468400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.744600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.795600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.245600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.887400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.761000E-01
Normal-vs-Daily Drinker
4.565000E-01
Normal-vs-Weekly Drinker
4.611600E-01
Normal-vs-Occasional Drinker
6.366000E-01
Normal-vs-Social Drinker
7.671000E-01
Non Drinker-vs-Daily Drinker
4.967000E-01
Non Drinker-vs-Weekly Drinker
5.446400E-01
Non Drinker-vs-Occasional Drinker
9.364000E-02
Non Drinker-vs-Social Drinker
7.011600E-01
Daily Drinker-vs-Weekly Drinker
9.863600E-01
Daily Drinker-vs-Occasional Drinker
2.565600E-02
Daily Drinker-vs-Social Drinker
3.153400E-01
Weekly Drinker-vs-Occasional Drinker
4.119700E-02
Weekly Drinker-vs-Social Drinker
3.444000E-01
Occasional Drinker-vs-Social Drinker
1.901160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.983600E-02
Normal-vs-Grade 2
3.884800E-01
Normal-vs-Grade 3
4.237500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.141240E-03
Grade 1-vs-Grade 3
1.592240E-04
Grade 1-vs-Grade 4
9.983600E-02
Grade 2-vs-Grade 3
4.027600E-02
Grade 2-vs-Grade 4
3.884800E-01
Grade 3-vs-Grade 4
4.237500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.156200E-01
Normal-vs-NonDiabetic
6.951400E-01
Diabetic-vs-NonDiabetic
9.372200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.179200E-01
Normal-vs-NoPancreatitis
6.682200E-01
Pancreatitis-vs-NoPancreatitis
3.073800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.923200E-01
Normal-vs-N1
7.261800E-01
N0-vs-N1
7.282800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.751800E-01
Normal-vs-TP53-NonMutant
5.540400E-01
TP53-Mutant-vs-TP53-NonMutant
1.445620E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
